Related Experiment Video
Updated: Apr 21, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Persistent vessel wall enhancement and progression of cerebral microbleeds in CADASIL: a case report
Wenjuan Xu1, Chao Zhang2, Xiaomin Liu3
1Department of General Practice, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Insights
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) shows persistent vessel wall enhancement on MRI, suggesting blood-brain barrier disruption. This finding may help understand disease progression in hereditary cerebral small vessel disease.
Area of Science:
- Neurology
- Radiology
- Genetics
Background:
- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a common hereditary cerebral small vessel disease (cSVD).
- It is primarily caused by NOTCH3 gene mutations and characterized by progressive neuroimaging findings like white matter hyperintensities and microbleeds.
- The underlying pathophysiology of neuroimaging progression in CADASIL is not fully understood.
Abstract:
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most prevalent hereditary cerebral small vessel disease (cSVD), primarily caused by pathogenic variants in the NOTCH3 gene. Neuroimaging features, including white matter hyperintensities (WMH), lacunar infarcts, and cerebral microbleeds (CMBs), typically progress with disease advancement. However, the pathophysiological mechanisms underlying this neuroimaging progression remain poorly understood. Here we present a patient with a NOTCH3 mutation who exhibited persistent vessel wall enhancement on serial high-resolution vessel wall MRI (VWMRI), alongside progression of CMBs. This finding supports a critical role of blood-brain barrier (BBB) disruption in CADASIL pathophysiology. In conclusion, persistent intracranial vessel wall enhancement may be observed in patients with CADASIL. Further studies are needed to investigate the relationship between this imaging biomarker and clinical as well as neuroimaging outcomes.
Related Concept Videos
Dementia l: Introduction
Cerebral Edema ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology

